Medication info

Simvastatin/Ezetimibe Tablets 10/10 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
HUBIST Pharmaceutical Co., Ltd.
Appearance
White to pale yellow, double convex rectangular tablets
Packaging
30 tablets/PTP[(10 tablets/PTPX3)]
Approval status
Expired

MFDS item code 201905982 · Approved 2019.08.23

This product's status changed to Expired on 2024.08.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start with 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be prescribed only to patients who have taken 10/80 mg of this medicine for at least 12 months without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5, General Precautions, subsection Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with concomitant chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. Use higher doses of this medicine cautiously in these patients and monitor them closely (see section 5, General Precautions, under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See section 6, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concurrently with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concurrently with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
HUBIST Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels, and increases HDL cholesterol in patients with primary hypercholesterolemia, especially those with heterozygous familial and non-familial hypercholesterolemia, and mixed hyperlipidemia. It can also be used as an alternative therapy in patients with homozygous familial hypercholesterolemia in conjunction with other lipid-lowering therapies or when other treatments are ineffective. This medication should be used alongside appropriate dietary measures and should be administered when there is insufficient response to non-pharmacological measures. Secondary causes such as diabetes and hypothyroidism should be checked and treated as necessary prior to therapy. It is important to conduct regular blood lipid tests in patients with severe hypercholesterolemia to monitor treatment effectiveness. This medication is effective in reducing the risk of atherosclerotic vascular disease through the treatment of hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start with 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be prescribed only to patients who have taken 10/80 mg of this medicine for at least 12 months without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5, General Precautions, subsection Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with concomitant chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. Use higher doses of this medicine cautiously in these patients and monitor them closely (see section 5, General Precautions, under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See section 6, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concurrently with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concurrently with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication helps to lower blood cholesterol levels. However, it is necessary to be cautious as it may cause muscle problems when taking this medication. Especially if muscle pain or weakness occurs, it should be reported to a doctor immediately. This medication can affect liver function, so it should not be taken if there is liver disease or elevated liver function tests. Women who are pregnant or breastfeeding should not use this medication. Taking it alongside certain medications that interact can increase the risk of muscle damage, so it must be discussed with a doctor. Caution is also needed for elderly patients and those with kidney disease. Additionally, regular liver function and muscle-related tests are recommended during treatment with this medication. If unexplained muscle pain, tenderness, or weakness occurs while taking this medication, treatment should be stopped immediately, and medical attention should be sought. It is essential to inform healthcare providers when starting a new medication while on this medication. In case of overdose, there is no specific antidote, and appropriate treatment should be sought at the hospital immediately.

Side effects

  • myopathy
  • rhabdomyolysis
  • increased creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 88 more
  • nausea
  • abdominal pain
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • rash
  • arthralgia
  • low back pain
  • taste disturbance
  • ophthalmoplegia
  • facial asymmetry
  • tremor
  • dizziness
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • weakness
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucosal erosion syndrome
  • erythema multiforme
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • hepatic failure
  • anorexia
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruptions
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the drug's efficacy and safety for a long time.

Appearance and packaging

Appearance

White to pale yellow, double convex rectangular tablets

Package unit

30 tablets/PTP[(10 tablets/PTPX3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.